Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Simcere Diagnostics, often referred to as Simcere Medtech, is a leading precision medicine company in China specializing in molecular diagnostics and companion diagnostics (CDx). As a key subsidiary of Simcere Pharmaceutical Group, the company focuses on oncology, infectious diseases, and pharmacogenomics to support personalized treatment decisions. Their portfolio includes advanced Next-Generation Sequencing (NGS) panels, digital PCR assays, and bioinformatics services designed for early screening, therapy selection, and minimal residual disease (MRD) monitoring. Simcere Diagnostics operates high-standard manufacturing facilities in Shandong and maintains extensive collaborations with global pharmaceutical companies to develop integrated diagnostic-therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Simcere Medtech.